Tenon Medical Statistics
Total Valuation
Tenon Medical has a market cap or net worth of $10.16 million. The enterprise value is $7.11 million.
Important Dates
The next estimated earnings date is Thursday, March 19, 2026, after market close.
| Earnings Date | Mar 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Tenon Medical has 11.11 million shares outstanding. The number of shares has increased by 1,031.03% in one year.
| Current Share Class | 11.11M |
| Shares Outstanding | 11.11M |
| Shares Change (YoY) | +1,031.03% |
| Shares Change (QoQ) | +8.68% |
| Owned by Insiders (%) | 7.14% |
| Owned by Institutions (%) | 3.06% |
| Float | 9.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.65 |
| Forward PS | 1.65 |
| PB Ratio | 4.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.15 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -197.26% and return on invested capital (ROIC) is -112.41%.
| Return on Equity (ROE) | -197.26% |
| Return on Assets (ROA) | -65.80% |
| Return on Invested Capital (ROIC) | -112.41% |
| Return on Capital Employed (ROCE) | -168.19% |
| Weighted Average Cost of Capital (WACC) | 11.07% |
| Revenue Per Employee | $119,741 |
| Profits Per Employee | -$474,481 |
| Employee Count | 27 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.18% in the last 52 weeks. The beta is 1.28, so Tenon Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.28 |
| 52-Week Price Change | -45.18% |
| 50-Day Moving Average | 1.04 |
| 200-Day Moving Average | 1.13 |
| Relative Strength Index (RSI) | 37.24 |
| Average Volume (20 Days) | 75,418 |
Short Selling Information
The latest short interest is 49,745, so 0.45% of the outstanding shares have been sold short.
| Short Interest | 49,745 |
| Short Previous Month | 116,099 |
| Short % of Shares Out | 0.45% |
| Short % of Float | 0.50% |
| Short Ratio (days to cover) | 1.01 |
Income Statement
In the last 12 months, Tenon Medical had revenue of $3.23 million and -$12.81 million in losses. Loss per share was -$2.24.
| Revenue | 3.23M |
| Gross Profit | 1.69M |
| Operating Income | -12.32M |
| Pretax Income | -12.81M |
| Net Income | -12.81M |
| EBITDA | -12.04M |
| EBIT | -12.32M |
| Loss Per Share | -$2.24 |
Full Income StatementBalance Sheet
The company has $3.44 million in cash and $216,000 in debt, with a net cash position of $3.23 million or $0.29 per share.
| Cash & Cash Equivalents | 3.44M |
| Total Debt | 216,000 |
| Net Cash | 3.23M |
| Net Cash Per Share | $0.29 |
| Equity (Book Value) | 4.80M |
| Book Value Per Share | 0.20 |
| Working Capital | 3.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.30 million and capital expenditures -$794,000, giving a free cash flow of -$12.09 million.
| Operating Cash Flow | -11.30M |
| Capital Expenditures | -794,000 |
| Free Cash Flow | -12.09M |
| FCF Per Share | -$1.09 |
Full Cash Flow StatementMargins
| Gross Margin | 52.40% |
| Operating Margin | -381.07% |
| Pretax Margin | -396.26% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Tenon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,031.03% |
| Shareholder Yield | -1,031.03% |
| Earnings Yield | -123.99% |
| FCF Yield | -117.03% |
Analyst Forecast
The average price target for Tenon Medical is $3.00, which is 227.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 227.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 55.63% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 6, 2024. It was a reverse split with a ratio of 1:8.
| Last Split Date | Sep 6, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
Tenon Medical has an Altman Z-Score of -13.04 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.04 |
| Piotroski F-Score | 1 |
